간 종양에 대한 Silk Thread Guided Laparoscopic Segmentectomy를 사용한 3차원 위치 접근법

Executive Industry Relevance

Accurate anatomical localization and margin determination are critical inflection points in surgical oncology and translational research for liver tumors. The 3D-LAST technique leverages advanced 3D imaging and preoperative planning to enhance intraoperative precision, supporting predictive confidence and risk-adjusted decision-making in complex resections. This capability aligns with enterprise R&D priorities for reproducible, scalable, and clinically actionable workflows.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables precise anatomical mapping to clarify surgical targets and boundaries.
• Supports biological de-risking by visualizing complex internal structures preoperatively.
• Improves predictive confidence in resection planning and outcome forecasting.

Screening & Assay Development

• Facilitates standardization of surgical margin determination for reproducible workflows.
• Provides quantitative volumetric outputs for downstream analysis and comparison.
• Prepares validated anatomical models for simulation and training applications.

Translational & Preclinical Research

• Aligns surgical planning with disease-relevant anatomical features for translational continuity.
• Enables risk-adjusted advancement decisions by integrating imaging and intraoperative data.
• Supports mechanistic de-risking through enhanced visualization of tumor and parenchyma relationships.

Pipeline & Workflow Integration

The 3D-LAST technique integrates into the discovery-to-preclinical continuum by bridging advanced imaging, surgical planning, and intraoperative execution.

• Discovery Biology: Provides hypothesis-driven anatomical mapping and margin prediction.
• Screening: Delivers reproducible, quantitative resection planning outputs for workflow standardization.
• Analytics: Enables volumetric and spatial measurements to compare surgical scenarios.
• Translational Research: Maintains continuity from imaging-based planning to intraoperative navigation.
• Enterprise Reuse: Offers a scalable, reusable platform for anatomical modeling and surgical simulation.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces anatomical ambiguity in surgical planning.
• Operational Value: Standardizes intraoperative navigation and margin determination for reproducibility.
• Strategic Value: Supports efficient go/no-go decisions and reduces late-stage procedural risk.
• Portfolio Impact: Enables risk-adjusted prioritization of surgical and translational research programs.

Implementation Considerations

• Requires expertise in 3D imaging, anatomical modeling, and surgical navigation.
• Depends on access to advanced CT imaging and computer post-processing infrastructure.
• Necessitates cross-team standardization of imaging and surgical protocols.
• Adaptation may vary across different anatomical models and tumor locations.
• Practical limitations include technical constraints of imaging and intraoperative marking methods.

Biopharma FAQs